Contrast-Enhanced Transcranial Doppler for Detecting Residual Leaks-A Single-Center Study on the Effectiveness of

Malwina Smolarek-Nicpoń1, Grzegorz Smolka1, Aleksandra Michalewska-Włudarczyk2

  • 1Department of Cardiology, School of Health Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.

Journal of Clinical Medicine
|September 27, 2025
PubMed

Insights

Patent foramen ovale (PFO) closure follow-up is essential. Contrast-enhanced transcranial Doppler (ce-TCD) effectively identifies residual leaks after PFO closure, guiding further treatment decisions.

Area of Science:

  • Cardiology
  • Neurology
  • Medical Imaging

Background:

  • A patent foramen ovale (PFO) is an atrial connection present in ~25% of the population.
  • PFO closure is indicated for embolic stroke of undetermined source (ESUS) or TIA in patients <60 years.
  • Post-closure follow-up monitors device position, closure efficacy, and thrombus formation.

Purpose of the Study:

  • To evaluate the effectiveness of percutaneous PFO closure using echocardiography and ce-TCD.
  • To assess long-term efficacy and identify residual embolic risk.
  • To determine the role of ce-TCD in detecting post-procedural complications.

Main Methods:

  • Analysis of 75 patients undergoing percutaneous PFO closure with ≥1 year follow-up.
  • Fluoroscopy and transesophageal echocardiography (TEE) for procedures; TEE for size selection.
  • Transthoracic echocardiography (TTE) at 1 and 6-12 months; ce-TCD at 12 months to detect high-intensity transient signals (HITSs).

Main Results:

  • No device dislodgement, thrombi, or residual leaks detected by TTE at follow-up.
  • ce-TCD identified HITSs in 8 patients; subsequent TEE confirmed residual leaks in 5 of 7 cases.
  • Two patients with grade 2 HITSs had confirmed leaks, indicating potential residual embolic risk.

Conclusions:

  • Assessing PFO occluder effectiveness is critical for managing residual embolic risk and antithrombotic therapy.
  • ce-TCD, even with low-grade HITSs, aids in identifying patients with residual leaks.
  • Early detection of leaks via ce-TCD and TEE can guide appropriate clinical management.